|
| General Information |
| Business: |
We are a clinical-stage specialty pharmaceutical company that is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. EGP-437, our first and only product in clinical trials, incorporates a reformulated topically active corticosteroid, dexamethasone phosphate, that is delivered into the ocular tissues though our proprietary innovative drug delivery system, the EyeGate® II Delivery System. |
|
| Industry: |
PHARMACEUTICAL PREPARATIONS |
|
| Employees: |
3 |
Founded: |
1998 |
|
| Contact Information |
| Address: |
271 Waverley Oaks Road, Suite 108, Waltham, MA 02452, US |
|
|
|
|
|
|
|
| Financial Information |
| |
| Revenues: |
$ 0.0 mil (last 12 months) |
|
| Net Income: |
$ -2.2 mil (last 12 months) |
|
| IPO Profile |
|
|
|
|
